Latest Sunitinib Stories
By LYNDSAY MOSS HEALTH CORRESPONDENT PATIENTS should be allowed to pay privately for cancer drugs and still keep their free NHS care in certain cases, the Scottish Government indicated yesterday.
London, UK: 04 September 2008 - Cancer drug developer Antisoma plc (LSE: ASM; USOTC: ATSMY) today announced that it has started a phase II study of AS1411 in metastatic renal cell carcinoma (kidney cancer).
By Emma Brady Midlands cancer patients are being kept in the dark about new treatments that could extend their lives, it was claimed today.
Leading UK cancer experts have accused a health watchdog of forcing patients to remortgage their homes to afford treatments freely available in Europe.
By Nicola Fenwick CANCER experts have accused a health watchdog of forcing patients to remortgage their homes to pay for treatments freely available in Europe.
The National Institute for Health and Clinical Excellence, UK has rejected four kidney cancer treatments for use on the National Health Service on grounds that the drugs are not cost effective, according to PharmaTimes.
By Gavin Engelbrecht THE Government?s drugs approval agency warned last night it might not be able to meet a pledge to speed up decision-making on new treatments.
Regarding the drug Sutent which was refused to Mrs Hopkins who dedicated 42 years of her life to the health service, all I can ask is how can we afford to give benefits to some of these immigrants who have never put a single penny into our communities? It seems to me the less you work, the more help you seem to get.
A Leading Welsh cancer specialist has condemned plans to prevent patients with advanced kidney cancer from getting specialised drug treatments.
By David Roberts A SURVEY has revealed more than 1,300 cancer patients nationwide are being denied vital drugs because of a ?postcode lottery? over who gets access to them.
- The governor of a province or people.